Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
Our objective was to show the unusual imaging characteristics of cystic liver metastases from a malignant gastrointestinal stromal tumor before and after treatment with imatinib mesylate.
Ulusan
Serife
S
Department of Radiology, Başkent University, Faculty of Medicine, Adana, Turkey. sulusan@hotmail.com
Koç
Zafer
Z
Kayaselçuk
Fazilet
F
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D003106:Colon / Q000473:pathology; D017809:Fatal Outcome; D046152:Gastrointestinal Stromal Tumors / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D007414:Intestinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D007421:Intestine, Small / Q000473:pathology; D008099:Liver / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D009361:Neoplasm Invasiveness; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013270:Stomach / Q000473:pathology; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy; D014463:Ultrasonography
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate